Therapy News and Research

RSS

Stair climbing study unveils surprising link to back pain in females but not males

Recent PLoS ONE research reveals that female orthopedic physical therapists without Low Back Pain (LBP) climb significantly more stairs weekly than those with LBP. Discrepancies in stair-climbing habits were more pronounced among females, with sleep quality differences also observed.

10 Oct 2023

Liquid biopsies could be used as an early marker of immunotherapy response, study finds

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).

9 Oct 2023

Study provides evidence for combination therapy as first-line treatment for relapsed ITP

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, conducted a multicenter comprehensive retrospective analysis to assess the effectiveness and safety of primary single-agent and combination therapies in treating adult patients with relapsed immune thrombocytopenia (ITP).

9 Oct 2023

Amsterdam's H-TEAM initiative on track to eradicate HIV with groundbreaking city-centered approach

Amsterdam's H-TEAM initiative has achieved a significant reduction in HIV infections from 2010 to 2022 using a city-centered approach. By combining treatments, including testing, pre-exposure prophylaxis, and stakeholder collaboration, the city has surpassed the UNAIDS 95-95-95 target and is on track to potentially eliminate HIV entirely in the near future.

9 Oct 2023

Gut's role in gout: New study unravels microbiome's influence on uric acid levels

In a comprehensive study, researchers explored the causal relationship between the gut microbiome, serological urate levels, and gout using Mendelian randomization. The findings reveal that certain genetically predicted gut microbial taxa influence uric acid levels and gout development, and vice versa, suggesting the gut microbiome as a potential therapeutic target for gout.

9 Oct 2023

FDA approves the use of sound waves to break down tumors in humans for liver treatment

The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.

9 Oct 2023

Compound found to inhibit influenza virus replication by targeting host enzyme

How can the propagation of influenza viruses be stopped? For a new approach in the therapy of influenza infections, Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 of the University of Bonn receives an Open Philanthropy grant of 2.2 million US dollars.

9 Oct 2023

Health experts redefine cardiovascular disease risk, prevention and management

Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association's flagship journal Circulation.

9 Oct 2023

Study compares effects of antidepressants with running exercises for depression and overall health

The first study to compare effects of antidepressants with running exercises for anxiety, depression and overall health shows that they have about the same benefits for mental health – but a 16-week course of running over the same period scores higher in terms of physical health improvement, whereas antidepressants lead to a slightly worse physical condition, as has been suggested by previous studies.

9 Oct 2023

Unlocking the Future of Mental Health Research: An Exclusive Interview with the CEO of MQ Mental Health Research

An Exclusive Interview with the CEO of MQ Mental Health Research.

9 Oct 2023

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Intrusive thoughts, involuntary repetition of undesirable gestures and behaviors combined with high anxiety... Obsessive-compulsive disorder (OCD), a disabling condition, affects around 2% of the population, regardless of age.

9 Oct 2023

Precision medicine for gestational diabetes management

Precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus.

9 Oct 2023

Is there an association between psoriasis onset and risk of autoimmune disease?

Researchers evaluated new-onset autoimmune disease risk among individuals with new-onset psoriatic illness.

9 Oct 2023

International report paves way for precision diabetes medicine breakthrough

Precision medicine for prevention, diagnosis, treatment, and prognosis for Diabetes.

9 Oct 2023

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.

From Sino Biological Inc. 9 Oct 2023

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

8 Oct 2023

Researchers explore immunomodulating targets for improving glioblastoma therapies

Researchers have delved into the intricate heterogeneity of glioblastoma, a notoriously aggressive brain tumor, using advanced single-cell RNA sequencing and innovative zebrafish avatars. Their findings spotlighted the LGALS1 gene's role in immunosuppression and suggested potential therapeutic avenues for personalized GBM treatment.

8 Oct 2023

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Gut microbiota's role in leukemia treatment responses is explored, with evidence suggesting diet and prebiotics may help manage microbiota alterations in patients. Diet during pregnancy, breastfeeding, and gut microbiota composition all intersect, potentially influencing leukemia risks and treatment outcomes.

8 Oct 2023

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment's efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.

8 Oct 2023

Study reveals key driver of metabolic rewiring in liver cancer cells

Cancer cells are chameleons. They completely change their metabolism to grow continuously. University of Basel scientists have discovered that high levels of the amino acid arginine drive metabolic reprogramming to promote tumor growth.

6 Oct 2023

Therapy News and Research

Stair climbing study unveils surprising link to back pain in females but not males

Liquid biopsies could be used as an early marker of immunotherapy response, study finds

Study provides evidence for combination therapy as first-line treatment for relapsed ITP

Amsterdam's H-TEAM initiative on track to eradicate HIV with groundbreaking city-centered approach

Gut's role in gout: New study unravels microbiome's influence on uric acid levels

FDA approves the use of sound waves to break down tumors in humans for liver treatment

Compound found to inhibit influenza virus replication by targeting host enzyme

Health experts redefine cardiovascular disease risk, prevention and management

Study compares effects of antidepressants with running exercises for depression and overall health

Unlocking the Future of Mental Health Research: An Exclusive Interview with the CEO of MQ Mental Health Research

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Precision medicine for gestational diabetes management

Is there an association between psoriasis onset and risk of autoimmune disease?

International report paves way for precision diabetes medicine breakthrough

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers explore immunomodulating targets for improving glioblastoma therapies

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Study reveals key driver of metabolic rewiring in liver cancer cells

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News